Phenylpiracetam — also known as Phenotropil or by its sport doping codename Carphedon — is the most stimulating member of the racetam family. Developed in Russia in 1983 at the Institute of Biomedical Problems, it was originally designed for cosmonauts to improve cognitive performance under the extreme stress of space travel: weightlessness, sleep deprivation, confined quarters, and the constant low-grade anxiety of orbital life.
In 2004, the World Anti-Doping Agency (WADA) added phenylpiracetam to its prohibited list — the only nootropic ever to receive that distinction. Olympic biathlete Olga Pyleva was stripped of her silver medal at the 2006 Winter Games after testing positive for it. That a cognitive enhancer was banned alongside anabolic steroids and EPO tells you something about phenylpiracetam's potency: it produces effects noticeable enough that international sport considers it cheating.
This guide covers what makes phenylpiracetam different from other racetams, the evidence behind it, and the critical tolerance issue that determines whether it remains effective or quickly becomes useless.
What makes phenylpiracetam different
Phenylpiracetam is, structurally, piracetam with a phenyl group attached to position 4 of the pyrrolidone ring. This single modification has dramatic consequences.
The phenyl group increases lipophilicity — the molecule's ability to dissolve in fats — which means phenylpiracetam crosses the blood-brain barrier far more efficiently than piracetam. This accounts for its 20–60× greater potency by weight. Where piracetam requires 1,200–4,800mg to produce noticeable cognitive effects, phenylpiracetam achieves comparable or stronger effects at just 100–200mg.
More importantly, the phenyl group adds properties that piracetam simply doesn't have. Phenylpiracetam has significant catecholamine-releasing activity — it increases dopamine and norepinephrine availability in the prefrontal cortex and striatum. This is why it feels stimulating rather than subtle. Where piracetam users describe a "clean, quiet" improvement in verbal fluency, phenylpiracetam users describe a noticeable surge in motivation, energy, and drive. The subjective experience is closer to a mild stimulant than to the typical racetam subtlety.
This catecholaminergic activity also explains phenylpiracetam's physical performance effects and its WADA ban — it genuinely enhances physical endurance and cold tolerance, not just cognition.
Cognitive and physical effects
Phenylpiracetam's effects are broader than most racetams, spanning both cognitive and physical domains:
- Focus and mental clarity: Users consistently report a sharp, clean focus that sets in within 30–60 minutes and persists for 4–6 hours. The quality is more "driven" than other racetams — it pushes you toward task completion rather than passively improving processing
- Increased motivation: The dopaminergic component produces genuine motivational enhancement. Tasks that feel tedious or aversive become easier to initiate. This is one of phenylpiracetam's most valued effects and distinguishes it from piracetam (which improves cognition but not motivation)
- Physical endurance: Russian research documented improved stamina and exercise tolerance. Cosmonauts used it for physical as well as cognitive demands. Athletes who were caught using it reported faster recovery between training sets and improved cold tolerance during winter sports
- Stress adaptation: The original cosmonaut research focused on cognitive maintenance under extreme environmental stress. Phenylpiracetam appears to buffer the cognitive effects of sleep deprivation, anxiety, and physical discomfort more effectively than other racetams
- Mood elevation: Many users report a subtle but noticeable improvement in mood — not euphoria, but a reduction in the baseline apathy or flatness that accompanies demanding work periods
Effects are noticeable within 30–60 minutes of oral dosing — dramatically faster than piracetam (which often takes days to weeks for effects to build) or Noopept. This rapid onset is part of phenylpiracetam's appeal and also contributes to its tolerance problem.
The research evidence
Phenylpiracetam's evidence base requires an honest appraisal. The primary research comes from Russian military and cosmonaut programmes, much of which has been translated from Russian-language journals. There are limited Western randomised controlled trials.
Russian clinical studies have demonstrated:
- Improved cognitive function in patients with cerebrovascular disease and post-stroke cognitive impairment
- Enhanced physical and cognitive performance under stress conditions (cold exposure, sleep deprivation, high-altitude simulation)
- Anxiolytic and antidepressant effects in patients with neurological conditions
- Improved recovery in traumatic brain injury patients
The stimulant-like effects are real and consistent with the substantial body of anecdotal evidence from the nootropic community. The specific cognitive enhancement claims in healthy subjects are harder to verify with the available published data — there is no large, well-designed Western RCT in healthy adults. However, the pharmacological profile (dopamine/norepinephrine release, enhanced BBB penetration, AMPA receptor modulation) provides a strong mechanistic basis for the reported effects.
WADA's decision to ban phenylpiracetam from competitive sport is itself a form of evidence — WADA does not ban substances without evidence of performance enhancement.
Dosing protocol
Phenylpiracetam dosing is straightforward, but the tolerance dimension makes the scheduling of doses far more important than the dose itself.
- Standard dose: 100mg, taken in the morning
- High dose: 200mg, split into two 100mg doses (morning and early afternoon) or taken as a single dose for high-demand days
- Onset: 30–60 minutes
- Duration: 4–6 hours of peak effects
- Maximum: 200mg per day — going higher increases side effects disproportionately to benefit
Critical: Tolerance builds extremely fast
Phenylpiracetam tolerance develops faster than any other racetam — sometimes within 2–3 consecutive days of use. After just 3 days of daily dosing, most users report significantly diminished effects. After a week of daily use, the stimulant quality is largely gone. This is not like modafinil tolerance (which builds over weeks) — it is rapid and pronounced.
The practical consequence: most experienced users dose phenylpiracetam no more than 2–3 times per week, with at least one day off between doses. Using it daily defeats the purpose. Some users reserve it exclusively for high-demand days — exam days, critical work deadlines, competition events — and never use it casually. This strategic approach preserves efficacy indefinitely.
Phenylpiracetam vs piracetam
| Property | Phenylpiracetam | Piracetam |
|---|---|---|
| Effective dose | 100–200mg | 1,200–4,800mg |
| Potency (by weight) | 20–60× more potent | Baseline |
| Onset | 30–60 minutes | Days to weeks (cumulative) |
| Stimulant quality | Pronounced — motivation, energy | Subtle — verbal fluency, clarity |
| Tolerance | Rapid — 2–3 days of daily use | Minimal — daily use is standard |
| Daily use viable | No — requires cycling | Yes — designed for chronic use |
| Physical performance | Yes — endurance, cold tolerance | No |
| WADA status | Banned | Permitted |
| Western evidence | Limited | Extensive — decades of RCTs |
The core trade-off: piracetam is a compound you can use every day as a cognitive baseline enhancer. Phenylpiracetam is a compound you deploy strategically for acute performance demands. They serve fundamentally different use cases. For a full piracetam overview, see our Piracetam guide.
Phenylpiracetam vs modafinil
Both phenylpiracetam and modafinil are used for the same purpose — cognitive and motivational enhancement on high-demand days. The comparison is instructive because it reveals where each compound excels.
- Duration: Modafinil lasts 12–15 hours — an entire working day and sometimes into the evening. Phenylpiracetam lasts 4–6 hours — a focused work session. For full-day coverage, modafinil is superior. For a targeted sprint, phenylpiracetam is more appropriate
- Intensity: Phenylpiracetam is subjectively more intense during its active window — sharper onset, more pronounced motivation and mood lift. Modafinil is smoother and steadier
- Mood effect: Phenylpiracetam produces better mood elevation for many users — a subtle positive lift. Modafinil is mood-neutral for most people or mildly flat
- Tolerance: Phenylpiracetam tolerance develops in days; modafinil tolerance develops over weeks with daily use. Both require cycling, but phenylpiracetam's cycling requirements are far stricter
- Legal status: Modafinil is a prescription medication (Schedule IV). Phenylpiracetam is unscheduled in most countries but banned by WADA for competitive athletes
For a full comparison, see our Modafinil guide.
Side effects
Phenylpiracetam is generally well-tolerated at recommended doses, but the stimulant component introduces side effects that other racetams lack:
- Anxiety and irritability: The most common complaint. The catecholaminergic activity that produces motivation can tip into agitation in anxiety-prone individuals or at higher doses
- Headaches: The classic racetam headache, caused by increased acetylcholine demand outstripping choline supply. Easily prevented with choline supplementation (see below)
- Insomnia: Taken after noon, phenylpiracetam can disrupt sleep. Always dose in the morning or early afternoon
- Appetite suppression: Mild but noticeable for some users during the active window
The rapid tolerance development is, paradoxically, a safety feature — it makes chronic abuse impractical. You can't maintain a phenylpiracetam habit because it simply stops working after a few days of continuous use.
Choline stacking
Like all racetams, phenylpiracetam increases acetylcholine turnover. Choline supplementation is strongly recommended:
- Alpha-GPC: 300mg per phenylpiracetam dose — the preferred choice for racetam stacking due to high choline content and efficient BBB penetration
- Citicoline: 250mg per dose — an alternative that adds uridine for additional neuroplasticity support
For a full comparison of choline sources, see our Alpha-GPC vs Citicoline guide.
Key takeaways
- Phenylpiracetam is the most stimulating racetam — 20–60× more potent than piracetam with pronounced motivational and physical effects
- Dose: 100–200mg, onset in 30–60 minutes, duration 4–6 hours
- Tolerance develops in 2–3 days of consecutive use — never dose daily
- Best used strategically: 2–3 times per week maximum, reserved for high-demand days
- WADA-banned — competitive athletes cannot use it
- Pair with Alpha-GPC (300mg) or citicoline (250mg) to prevent headaches
- Evidence base is primarily Russian — limited Western RCTs in healthy subjects
Medical disclaimer
This article is for educational purposes only. Phenylpiracetam is not FDA-approved for any medical condition. Consult a healthcare professional before starting any supplement. Phenylpiracetam is prohibited by WADA in competitive sport.
Related guides
- Piracetam Guide — the original racetam and phenylpiracetam's parent compound.
- Racetam Comparison Guide — how phenylpiracetam compares to aniracetam, oxiracetam, and Noopept.
- Alpha-GPC vs Citicoline — the essential choline stacking guide for racetam users.
- Modafinil Guide — the other popular strategic cognitive enhancer, compared.